SOLVOTRIN THERAPEUTICS
Solvotrin Therapeutics Limited is a privately held pharmaceutical company focused on cardiovascular applications. Solvotrin’s business model is based on the development of new drugs that combine its unique patented prodrug platform with well established compounds in large markets. Its approach of chemically creating new chemical entities from existing compounds for synergistic benefits creates efficacy and safety advantages with significantly reduced development timeline and development ris... k. Solvotrin’s lead compound, ST0702 is a nicotinic acid prodrug, with significant efficacy and tolerability advantages over similar products for 54 dyslipidaemia. ST0701 is a bioactivated form of aspirin, which addresses the well documented gastrointestinal toxicity of aspirin. ST0703 is a ’nitro-aspirin‘ prodrug with dual antiplatelet effects and disease modifying potential. The company has a strong intellectual property underpin with patent protection at the highest, New Molecule level. Solvotrin’s strategy is to take its compounds to the end of Phase I and to partner the development and commercialisation phases with large pharmaceutical companies.
SOLVOTRIN THERAPEUTICS
Social Links:
Industry:
Chemical Medical Pharmaceutical
Founded:
2009-01-01
Address:
Cork, Cork, Ireland
Country:
Ireland
Website Url:
http://www.solvotrin.com
Total Employee:
11+
Status:
Active
Contact:
+353 (021) 4510220
Email Addresses:
[email protected]
Total Funding:
12.33 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Anticimex AB
Anticimex AB is a modern pest control company which provides preventative pest control.
Becanex
Becanex is a patented cannabis extraction company.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Botanix Pharmaceuticals
Botanix Pharmaceuticals is a pharmaceutical company that focuses on the treatment of skin diseases.
Lysoform Dr. Hans Rosemann
Lysoform Dr. Hans Rosemann is a pharmaceutical company that offers a range of disinfectant chemical preparation and sanitation solutions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Current Employees Featured
Founder
Investors List
RAB Capital
RAB Capital investment in Venture Round - Solvotrin Therapeutics
Elkstone Capital Partners
Elkstone Capital Partners investment in Venture Round - Solvotrin Therapeutics
Elkstone Capital Partners
Elkstone Capital Partners investment in Venture Round - Solvotrin Therapeutics
Kevin Fielding
Kevin Fielding investment in Venture Round - Solvotrin Therapeutics
Enterprise Ireland
Enterprise Ireland investment in Venture Round - Solvotrin Therapeutics
Official Site Inspections
http://www.solvotrin.com
- Host name: redirection.constellix.com
- IP address: 208.80.122.160
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Solvotrin Therapeutics"
Our Company - Active Iron
Our Company. Solvotrin Therapeutics is an Irish healthcare development company focused on optimising established therapies through innovation with patent protection. Headquartered in …See details»
Solvotrin Therapeutics - Crunchbase Company Profile & Funding
Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications.See details»
Solvotrin Therapeutics Ltd - Company Profile
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. Solvotrin’s intellectual property offers a major opportunity with novel, patent …See details»
Solvotrin Therapeutics Company Profile - Craft
Solvotrin Therapeutics has 5 employees at their 1 location and $4.38 m in total funding,. See insights on Solvotrin Therapeutics including office locations, competitors, revenue, financials, …See details»
SOLVOTRIN THERAPEUTICS LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SOLVOTRIN THERAPEUTICS LIMITED of Douglas. Get the latest business insights from Dun & Bradstreet.See details»
Solvotrin Therapeutics - 2025 Company Profile - Tracxn
Feb 26, 2025 Solvotrin Therapeutics is focused on the development of supplements. Its lead product, ST1406 (also known as ACTIVE IRON) is a ferrous sulfate supplement and was …See details»
Solvotrin Therapeutics Company Profile | Management and
Find contact information for Solvotrin Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Solvotrin Therapeutics's email format.See details»
Active Iron – Ultra Pharma
Active Iron Solvotrin Therapeutics is an Irish healthcare development company focused on optimising established therapies through innovation with patent protection. Headquartered in Co. Cork, Ireland, Solvotrin has a growing team …See details»
Solvotrin Therapeutics - VentureRadar
"Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. Solvotrin’s intellectual property offers a major opportunity with novel, patent …See details»
Solvotrin - Trinity College Dublin
Solvotrin Solvotrin is a TCD spin out Developing active iron, aspirin prodrugs, tetracycline nitrates Based in Little Island, Cork Employs ten people between Cork and TCDSee details»
Solvotrin Therapeutics Ltd.: Drug pipelines, Patents, Clinical trials ...
Explore Solvotrin Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, , Drug:ST-0703, ST-0701.See details»
Solvotrin Therapeutics Announces Exclusive Agreement with Ortho ...
About Solvotrin Therapeutics Solvotrin Therapeutics is an Irish healthcare development company focused on optimizing established therapies through innovation and patent protection. The …See details»
Solvotrin Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Solvotrin Therapeutics. See Solvotrin Therapeutics company profile and funding data.See details»
Supplements group Solvotrin raises €6.7m to fund China, US …
Nov 2, 2020 Solvotrin Therapeutics, a Cork-based supplements group, has raised €6.7 million in funding from new and existing investors as it looks to expand in China and the US. The latest …See details»
Get To Know: Irish Iron Specialist Solvotrin Therapeutics
Oct 9, 2023 Irish firm Solvotrin Therapeutics markets its Active Iron supplement brand across 14 international markets including the UK, US and China.See details»
Solvotrin Therapeutics - Funding, Financials, Valuation & Investors
Nov 2, 2020 Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications.See details»
Our Company - Active Iron
Our Company. Solvotrin Therapeutics is an Irish healthcare development company focused on optimizing established therapies through innovation with patent protection. Headquartered in …See details»
Solvotrin Therapeutics - VentureRadar
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. Solvotrin’s intellectual property offers a major opportunity with novel, patent …See details»
Irish company invents super aspirin with no side effects
Apr 23, 2010 Solvotrin has spent $1.35 million on drug research and they are "very confident" that the drug to be approved by pharmaceutical regulators.See details»
Solvotrin Announces Long-Term Licensing Agreement with …
Solvotrin Therapeutics partners with Norwell Consumer Healthcare to launch Active Iron in Canada in 2025. This clinically proven iron supplement will enhance Norwell’s Welivaâ„¢ brand, …See details»